- Home
- GL vs BMRN Comparison
GL vs BMRN Comparison
Compare GL & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GL
- BMRN
- Stock Information
- Founded
- GL 1900
- BMRN 1996
- Country
- GL United States
- BMRN United States
- Employees
- GL N/A
- BMRN N/A
- Industry
- GL Life Insurance
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- GL Finance
- BMRN Health Care
- Exchange
- GL Nasdaq
- BMRN Nasdaq
- Market Cap
- GL 11.0B
- BMRN 10.0B
- IPO Year
- GL N/A
- BMRN 1999
- Fundamental
- Price
- GL $132.21
- BMRN $51.52
- Analyst Decision
- GL Buy
- BMRN Buy
- Analyst Count
- GL 10
- BMRN 19
- Target Price
- GL $150.90
- BMRN $90.26
- AVG Volume (30 Days)
- GL 610.7K
- BMRN 2.8M
- Earning Date
- GL 10-22-2025
- BMRN 10-27-2025
- Dividend Yield
- GL 0.82%
- BMRN N/A
- EPS Growth
- GL 16.72
- BMRN 59.53
- EPS
- GL 13.77
- BMRN 2.68
- Revenue
- GL $5,940,974,000.00
- BMRN $3,094,001,000.00
- Revenue This Year
- GL $7.51
- BMRN $13.32
- Revenue Next Year
- GL $5.15
- BMRN $7.51
- P/E Ratio
- GL $9.60
- BMRN $19.20
- Revenue Growth
- GL 3.73
- BMRN 12.39
- 52 Week Low
- GL $100.27
- BMRN $50.76
- 52 Week High
- GL $147.83
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- GL 42.01
- BMRN 40.53
- Support Level
- GL $127.85
- BMRN $51.80
- Resistance Level
- GL $134.62
- BMRN $53.49
- Average True Range (ATR)
- GL 2.42
- BMRN 1.84
- MACD
- GL -0.02
- BMRN -0.08
- Stochastic Oscillator
- GL 44.37
- BMRN 12.58
About GL Globe Life Inc.
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.